  Osteosarcoma is the most common bone tumor in children and young adults , with few advances in survival and treatment , especially for metastatic disease , in the last 30 years. Recently , immunotherapy has begun to show promise in various adult cancers , but the utility of this approach for osteosarcoma remains relatively unexplored. In this review , we outline the mechanisms and status of immunotherapies currently in clinical trials as well as future therapies on the horizon , and discuss their potential application for osteosarcoma.